Clinical Trials

172 enrolled

Lymphoma

NCT05293028 2022-03-23

Study of F527 in Patients With Relapsed or Refractory Lymphoma

82 enrolled

Lymphoma

NCT05049083 2022-01-14

A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects

28 enrolled

Lymphoma

NCT04014894 2021-11-12

ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma

9 enrolled

Leukemia, Lymphoma

NCT04818372 2021-11-12

Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma

87 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT03374007 2021-08-16

GB226

72 enrolled

Hodgkin Disease, Lymphoma

NCT03852823 2021-04-30

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

GynecologicLymphoidOther solid neoplasmThoracic

192 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lymphoma

NCT02546739 2021-01-26

Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL

100 enrolled

Leukemia, Lymphoma

NCT03271515 2021-01-20

Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL

20 enrolled

Leukemia, Lymphoma

NCT03921879 2020-10-23

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

50 enrolled

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT03836690 2019-10-25

ToTem

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

18 enrolled

Primary Immunodeficiency Diseases, Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT02836834 2019-10-22

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors

33 enrolled

LymphoidThoracic

Lung Neoplasms, Lymphoma

NCT03991559 2019-08-28

A Safety Study of the Pan-immunotherapy in Patients With Unresectable/Metastatic Solid Tumors or Lymphomas

20 enrolled

Lymphoma, Neoplasm Metastasis

NCT03932955 2019-05-01

MC-19PD1 CAR-T in Relapsed or Refractory B Cell Lymphoma

15 enrolled

Lymphoma

NCT03821363 2019-01-29

Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma

206 enrolled

Lymphoma, Neoplasms

NCT03731390 2018-11-06

GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma

Lymphoma, Neoplasms

NCT03540303 2018-05-30

Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma

15 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

NCT02822326 2017-09-11

Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia

Leukemia, Lymphoma

NCT02656147 2017-09-05

Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL

48 enrolled

Leukemia, Lymphoma

NCT01439750 2017-08-07

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

13 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT03121625 2017-04-25

CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

Leukemia, Lymphoma

NCT02441972 2017-03-10

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

BreastHead & NeckLymphoid

200 enrolled

Breast Neoplasms, Carcinoma, Bronchogenic, Head and Neck Neoplasms, Lymphoma, Neoplasms, Soft Tissue Neoplasms

NCT02933775 2016-10-14

CD19-redirected Autologous Cells (CAR-CD19 T Cells)

45 enrolled

Lymphoma

NCT02131688 2014-05-06

Phase I Study of Mitoxantrone Hydrochloride Liposome Injection

Lymphoma

NCT01884428 2014-01-29

Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma

24 enrolled

Hodgkin Disease, Lymphoma

NCT00006100 2013-12-18

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

Hodgkin Disease, Lymphoma

NCT00004858 2013-09-20

Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00009776 2013-09-20

Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00023816 2013-09-20

Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma

DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00324597 2013-09-17

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

DermatologicLymphoidOther hematologic neoplasmThoracic

18 enrolled

Adenocarcinoma of Lung, Burkitt Lymphoma, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lung Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00562068 2013-08-26

Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00008021 2013-08-07

Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00592163 2012-07-19

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

20 enrolled

Lymphoma, Neoplasms

NCT00003073 2010-03-23

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

CNSLymphoidOther hematologic neoplasmSarcoma

15 enrolled

Burkitt Lymphoma, Leukemia, Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Meningeal Carcinomatosis

NCT00053105 2009-07-07

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

DermatologicLymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous

NCT00004086 2009-06-09

Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer